We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
Price data last checked 37 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 54 days · 54 data points (no recent data)
Price Distribution
Price distribution over 54 days • 1 price levels
Price Analysis
Most common price: £495 (54 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 54 days
Product Specifications
- Format
- paperback
- ASIN
- B0BBJDFGQP
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 16 August 2022
- Listed Since
- 25 August 2022
Similar Products You Might Like
The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan
The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
Price unavailable
The 2023-2028 Outlook for Chronic Myelogenous Leukemia Treatments for US Zip Codes
Multiple Myeloma - An Overview
IntechOpen
Multiple Myeloma
IntechOpen
New Developments in Myeloma, An Issue of Hematology/Oncology Clinics of North America: Volume 38-2 (The Clinics: Internal Medicine, Volume 38-2)
Elsevier
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China
The 2016-2021 Outlook for Hematology and Oncology Products in Europe
Molecular Insights for Drug-Delivery System Design for Multiple Myeloma: A nano/micro approach (IPEM-IOP Series in Physics and Engineering in Medicine and Biology)
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
The 2016-2021 Outlook for Hematology and Oncology Products in Asia
The 2016-2021 Outlook for Hematology and Oncology Products in the Middle East
The 2016-2021 Outlook for Hematology and Oncology Products in North America & the Caribbean
The 2016-2021 Outlook for Hematology and Oncology Products in India
The 2016-2021 Outlook for Hematology and Oncology Products in Greater China
Update on Multiple Myeloma
IntechOpen
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
The 2021-2026 World Outlook for Hematology and Oncology Products
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
